This post is written by incoming ACC President David Holmes, MD, FACC, who made the TCT announcement this morning at the TCT symposium.

****************** 

Exciting news fromTCT (for those of you who are unfamiliar, Transcatheter Cardiovascular Therapeutics is the annual medical and scientific symposium of the Cardiovascular Research Foundation): The ACC will become an official co-sponsor of the annual TCT symposium beginning in 2011. Future meetings will be known as “Transcatheter Cardiovascular Therapeutics in Partnership with ACC.”

What does this mean? Basically, the new partnership enhances an existing partnership that the ACC already has with CRF. Back in 2008, the ACC and CRF signed an agreement where CRF agreed to help coordinate the interventional content at ACC’s annual i2 Summit.

Today’s announcement means the two groups will work together on a partnership that involves sharing content and distribution of educational materials. The ACC and CRF will form a physician-led “Collaborative Council” of senior physician leaders that will meet regularly to review progress towards established objectives and to set the strategic direction of the affiliation. ACC and CRF staff will also meet regularly to share best practices, consider joint procurement of vendors, consider reciprocal exposition space at annual meetings, and explore collaboration around industry training programs.

There's nothing more important than education. The ACC and CRF believes that this collaboration will enhance and expand the educational opportunities available to interventional cardiovascular professionals, so that they are better prepared to translate evidence-based science into clinical practice. CRF has been helping the ACC with i2 Summit for the last two years, and now we're returning the favor for their meeting. Basically, we're making a great meeting even better. Like we're two kids (more like grown ups) holding hands as we cross over the intersection of Educational Avenue and Cutting Edge Clinical Science Boulevard.

CardioSource has full coverage of TCT’s major trials. 

*************

Please note that statements or opinions expressed herein reflect the views of the contributor, and do not reflect the official views of the ACCF, unless otherwise noted. 

< Back to Listings